S. Sener Et Al. , "Treatment of childhood-onset Takayasu arteritis: Switching between anti-TNF and anti-IL-6 agents," Rheumatology (United Kingdom) , vol.61, no.12, pp.4885-4891, 2022
Sener, S. Et Al. 2022. Treatment of childhood-onset Takayasu arteritis: Switching between anti-TNF and anti-IL-6 agents. Rheumatology (United Kingdom) , vol.61, no.12 , 4885-4891.
Sener, S., BAŞARAN, H. Ö., KAYA AKCA, Ü., Atalay, E., Kasap Cuceoglu, M., Balik, Z., ... Aliyev, E.(2022). Treatment of childhood-onset Takayasu arteritis: Switching between anti-TNF and anti-IL-6 agents. Rheumatology (United Kingdom) , vol.61, no.12, 4885-4891.
Sener, Seher Et Al. "Treatment of childhood-onset Takayasu arteritis: Switching between anti-TNF and anti-IL-6 agents," Rheumatology (United Kingdom) , vol.61, no.12, 4885-4891, 2022
Sener, Seher Et Al. "Treatment of childhood-onset Takayasu arteritis: Switching between anti-TNF and anti-IL-6 agents." Rheumatology (United Kingdom) , vol.61, no.12, pp.4885-4891, 2022
Sener, S. Et Al. (2022) . "Treatment of childhood-onset Takayasu arteritis: Switching between anti-TNF and anti-IL-6 agents." Rheumatology (United Kingdom) , vol.61, no.12, pp.4885-4891.
@article{article, author={Seher Sener Et Al. }, title={Treatment of childhood-onset Takayasu arteritis: Switching between anti-TNF and anti-IL-6 agents}, journal={Rheumatology (United Kingdom)}, year=2022, pages={4885-4891} }